Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

A tissue graft model of DNA damage response in the normal and malignant human prostate.

Af Hällström TM, Zhao H, Tian J, Rantanen V, Reese SW, Nolley R, Laiho M, Peehl DM.

J Urol. 2014 Mar;191(3):842-9. doi: 10.1016/j.juro.2013.09.007. Epub 2013 Sep 11.

2.

Defective DNA strand break repair after DNA damage in prostate cancer cells: implications for genetic instability and prostate cancer progression.

Fan R, Kumaravel TS, Jalali F, Marrano P, Squire JA, Bristow RG.

Cancer Res. 2004 Dec 1;64(23):8526-33.

3.

Tissue slice grafts: an in vivo model of human prostate androgen signaling.

Zhao H, Nolley R, Chen Z, Peehl DM.

Am J Pathol. 2010 Jul;177(1):229-39. doi: 10.2353/ajpath.2010.090821. Epub 2010 May 14.

4.

DNA damage recognition via activated ATM and p53 pathway in nonproliferating human prostate tissue.

Jäämaa S, Af Hällström TM, Sankila A, Rantanen V, Koistinen H, Stenman UH, Zhang Z, Yang Z, De Marzo AM, Taari K, Ruutu M, Andersson LC, Laiho M.

Cancer Res. 2010 Nov 1;70(21):8630-41. doi: 10.1158/0008-5472.CAN-10-0937. Epub 2010 Oct 26.

5.

Optimization and comprehensive characterization of a faithful tissue culture model of the benign and malignant human prostate.

Maund SL, Nolley R, Peehl DM.

Lab Invest. 2014 Feb;94(2):208-21. doi: 10.1038/labinvest.2013.141. Epub 2013 Dec 2.

6.

Radioprotection and cell cycle arrest of intestinal epithelial cells by darinaparsin, a tumor radiosensitizer.

Tian J, Doi H, Saar M, Santos J, Li X, Peehl DM, Knox SJ.

Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1179-85. doi: 10.1016/j.ijrobp.2013.08.051. Epub 2013 Oct 24.

PMID:
24210080
7.

Differential contextual responses of normal human breast epithelium to ionizing radiation in a mouse xenograft model.

Coates PJ, Appleyard MV, Murray K, Ackland C, Gardner J, Brown DC, Adamson DJ, Jordan LB, Purdie CA, Munro AJ, Wright EG, Dewar JA, Thompson AM.

Cancer Res. 2010 Dec 1;70(23):9808-15. doi: 10.1158/0008-5472.CAN-10-1118. Epub 2010 Nov 16.

8.

Development and characterization of efficient xenograft models for benign and malignant human prostate tissue.

Wang Y, Revelo MP, Sudilovsky D, Cao M, Chen WG, Goetz L, Xue H, Sadar M, Shappell SB, Cunha GR, Hayward SW.

Prostate. 2005 Jul 1;64(2):149-59.

PMID:
15678503
9.

An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line.

Wang Y, Xue H, Cutz JC, Bayani J, Mawji NR, Chen WG, Goetz LJ, Hayward SW, Sadar MD, Gilks CB, Gout PW, Squire JA, Cunha GR, Wang YZ.

Lab Invest. 2005 Nov;85(11):1392-404.

10.

Attenuated response of p53 and p21 in primary cultures of human prostatic epithelial cells exposed to DNA-damaging agents.

Girinsky T, Koumenis C, Graeber TG, Peehl DM, Giaccia AJ.

Cancer Res. 1995 Sep 1;55(17):3726-31.

11.

Testosterone promotes DNA damage response under oxidative stress in prostate cancer cell lines.

Ide H, Lu Y, Yu J, China T, Kumamoto T, Koseki T, Yamaguchi R, Muto S, Horie S.

Prostate. 2012 Sep 15;72(13):1407-11. doi: 10.1002/pros.22492. Epub 2012 Jan 30.

PMID:
22290195
12.

Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue.

Wang Y, Hayward SW, Donjacour AA, Young P, Jacks T, Sage J, Dahiya R, Cardiff RD, Day ML, Cunha GR.

Cancer Res. 2000 Nov 1;60(21):6008-17.

14.

Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.

Simak R, Capodieci P, Cohen DW, Fair WR, Scher H, Melamed J, Drobnjak M, Heston WD, Stix U, Steiner G, Cordon-Cardo C.

Histol Histopathol. 2000 Apr;15(2):365-74.

PMID:
10809354
15.

Induction of DNA damage and ATF3 by retigeric acid B, a novel topoisomerase II inhibitor, promotes apoptosis in prostate cancer cells.

Liu Y, Gao F, Jiang H, Niu L, Bi Y, Young CY, Yuan H, Lou H.

Cancer Lett. 2013 Aug 28;337(1):66-76. doi: 10.1016/j.canlet.2013.05.022. Epub 2013 May 18.

PMID:
23693077
16.

Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.

Wu GJ, Wu MW, Wang SW, Liu Z, Qu P, Peng Q, Yang H, Varma VA, Sun QC, Petros JA, Lim SD, Amin MB.

Gene. 2001 Nov 14;279(1):17-31.

PMID:
11722842
17.
18.

Genetic changes and DNA damage responses in the prostate.

Hällström TM, Laiho M.

Prostate. 2008 Jun 1;68(8):902-18. doi: 10.1002/pros.20746. Review.

PMID:
18324675
19.

p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis.

Parsons JK, Gage WR, Nelson WG, De Marzo AM.

Urology. 2001 Oct;58(4):619-24.

PMID:
11597556
20.

ATM activation is accompanied with earlier stages of prostate tumorigenesis.

Fan C, Quan R, Feng X, Gillis A, He L, Matsumoto ED, Salama S, Cutz JC, Kapoor A, Tang D.

Biochim Biophys Acta. 2006 Oct;1763(10):1090-7. Epub 2006 Aug 24.

Items per page

Supplemental Content

Write to the Help Desk